For example, impaired AGGF1 level is detected in bladder urothelial carcinoma (Xu et al., 2014) whereas increased AGGF1 level is observed in hepatocellular carcinoma. This evidence concerns the gene AGGF1 and bladder transitional cell carcinoma.